News

Pembrolizumab significantly reduced the risk of event free survival events by 30% compared with standard of care.
The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).
Widaplik is indicated for the treatment of hypertension, including as initial treatment, to lower blood pressure.
HealthDay News — For critically ill adults with sepsis, statin use is associated with reduced mortality, according to a study published online June 5 in Frontiers in Immunology.
In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9% with early and late discontinuation and nondiscontinuation, respectively.
Some FDA staff said Elsa often gave wrong answers, what experts call “hallucinations”, and has to be double-checked.
The US Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr named 8 new members to the Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization ...
The approval was based on two phase 1 crossover studies, which compared zanubrutinib tablets with the capsule formulation in healthy adult participants.
HealthDay News — Mailed self-collection (SC) kits may increase participation in cervical cancer screening, according to a study published online June 6 in JAMA Internal Medicine.
HealthDay News — A healthy diet improves cardiometabolic risk factors, even if not associated with weight loss (WL), according to a study published online June 5 in the European Journal of Preventive ...
HealthDay News — Health care employment growth decreased during the pandemic but recovered by 2024, according to a research letter published online June 5 in the Journal of the American Medical ...
The ACIP is a federal advisory committee composed of medical and public health experts who make recommendations on the use of vaccines for adults and children in the US.